No abstract

Colorectal cancer (CRC) is one of the most common cancers in the world. When treating patients, therapeutic agents have side effects; hence, the use of natural compounds found in medicinal plants including pomegranate. Ultrasound assisted extraction (UAE) is a new technique evolving to the detriment of traditional methods such as maceration. In this study, we investigated the antioxidant and anticancer effect of pomegranate peel extracts obtained by maceration and UAE at three different ultrasonic power levels (P1 = 10 W; P2 = 50 W; P3 = 100 W) on HCT-116 colorectal cancer cells. Phytochemical screening highlighted the presence of primary and secondary metabolites in pomegranate peels. In addition, the ethanolic extract obtained by UAE at 50 W was shown to be the most concentrated in phenolic and flavonoid compounds and have the most powerful antioxidant activity, which reached a maximum activity of 92% as determined by DPPH test. Similarly, the MTT cell viability test showed that the extract obtained by UAE at 50 W had the most potent inhibitory effect compared to the other extracts. In conclusion, the UAE at 50 W was shown to be the most suitable and efficient extraction technique to obtain bioactive compounds from pomegranate peel extracts that can be used in the treatment of CRC.

The effect of ascorbic acid and lactose on the interaction between iron and each of zinc or copper during intestinal absorption was studied in normal and iron-deficient rats. It was found that addition of cobalt to the iron dose inhibited absorption of iron to 42% in normal rats and to 46.7% in iron deficient ones. The presence of zinc with the iron dose also inhibited absorption of iron to 34.6% in normal rats and to 32.2% in case of the iron deficient ones. The addition of ascorbic acid to the combined dose of Fe + Co enhanced absorption of iron by five times in normal and in iron deficient rats. In case of the combined dose of Fe + Zn the enhancement was four times in normal rats and six times in iron deficient ones. The addition of lactose to the combined dose of either Fe + Co or Fe + Zn corrected the inhibiting action of either cobalt or zinc on iron absorption. Based on these findings, it is recommended that ascorbic acid and lactose be added to therapeutic multimineral preparations.